| Recruiting | N/A | 900 | Europe | Non-impositive Program for Optimizing the Use of Antimicrobials | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Bacterial Infections, Fungal Infection | 12/20 | 12/22 | | |
EDIT-CMD, NCT04777045: Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial |
|
|
| Active, not recruiting | 3 | 85 | Europe | Diltiazem Hydrochloride, Molecular Formula: C22H26N2S.HCl, Diltiazem HCl Retard 120 mg, Prolonged-Release Tablets, CAS 33286-22-5, Chemically diltiazem hydrochloride is the hydrochloride salt of (2S, 3S)-5-(2- Dimethylaminoethyl)- 2, 3, 4, 5-tetrahydro-2-(4-methoxyphenyl)-4-oxo-1, 5-benzothiazepin-3- yl-acetate, Placebo | Radboud University Medical Center | Microvascular Angina, Coronary Vasospasm, Microvascular Ischemia of Myocardium | 07/26 | 12/26 | | |
| Enrolling by invitation | 2/3 | 100 | Europe | Endothelin Receptor Antagonist, Bosentan, Placebo control, Placebo | Radboud University Medical Center, UMC Utrecht, Catharina Ziekenhuis Eindhoven, Maasstad Hospital | Coronary Spasm | 06/26 | 07/26 | | |
| Recruiting | N/A | 671 | Europe, RoW | | CoreAalst BV, Hexacath, France | Coronary Microvascular Disease | 09/26 | 09/30 | | |
